摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[2-Fluoro-5-(fluoromethyl)phenyl]-2,2-dimethylpropan-1-one

中文名称
——
中文别名
——
英文名称
1-[2-Fluoro-5-(fluoromethyl)phenyl]-2,2-dimethylpropan-1-one
英文别名
1-[2-fluoro-5-(fluoromethyl)phenyl]-2,2-dimethylpropan-1-one
1-[2-Fluoro-5-(fluoromethyl)phenyl]-2,2-dimethylpropan-1-one化学式
CAS
——
化学式
C12H14F2O
mdl
——
分子量
212.24
InChiKey
RZPAVUBSRAUHNO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    3

文献信息

  • METHOD FOR SCREENING ANTI-CANCER DRUGS AND METHOD OF CANCER TREATMENT
    申请人:National Taiwan University
    公开号:US20140148482A1
    公开(公告)日:2014-05-29
    The present application provides a method for screening compounds for cancer treatment comprising treating cancer cells with a candidate compound for sufficient time for detectable expression of a gene selected from GADD45 family; and detecting the level of expression of the gene as compared to the level of expression in the absence of the candidate compound; wherein an increased level of expression in the presence of the candidate compound as compared to expression in the absence of the candidate compound indicates that the candidate compound acts as an inhibitor of the cancer cells. In some embodiments, the method can be used for screening compounds for treatment of sorafenib-resistant hepatocellular carcinoma. The present application further provides a method for treating hepatocellular carcinoma comprising administering to a subject having hepatocellular carcinoma a therapeutic effective amount of an agonist of GADD45 family.
  • AGONISTS OF SRC HOMOLOGY-2 CONTAINING PROTEIN TYROSINE PHOSPHATASE-1 AND TREATMENT METHODS USING THE SAME
    申请人:Shiau Chung-Wai
    公开号:US20140200239A1
    公开(公告)日:2014-07-17
    The present invention provides new compounds of formula I, II or III, which have Src homology-2 containing protein tyrosine phosphatase-1 (SHP-1) agonist activity. Also provided are treatment methods using the compounds of formula I, II or III.
  • US9090617B1
    申请人:——
    公开号:US9090617B1
    公开(公告)日:2015-07-28
  • US9216950B2
    申请人:——
    公开号:US9216950B2
    公开(公告)日:2015-12-22
查看更多